Menü
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

Erstellt von Judge 

UnitedHealth Group Inc. diskutieren

UnitedHealth Group Inc.

WKN: 869561 / Symbol: UNH / Name: UnitedHealth / Aktie / Anbieter & Dienstleistungen / Large Cap /

382,40 €
-0,10 %

Einschätzung Buy
Rendite (%) 8,05 %
Kursziel 397,87
Veränderung
Endet am 17.06.27

UnitedHealth Group (UNH) had its price target raised by Leerink Partners from $400.00 to $462.00. They now have an "outperform" rating on the stock.
Ratings data for UNH provided by MarketBeat

UnitedHealth Group (UNH) had its "buy" rating reaffirmed by TD Cowen.
Ratings data for UNH provided by MarketBeat

UnitedHealth Group (UNH) had its "outperform" rating reaffirmed by Sanford C. Bernstein.
Ratings data for UNH provided by MarketBeat

Einschätzung Buy
Rendite (%) 7,20 %
Kursziel 417,95
Veränderung
Endet am 24.06.27

UnitedHealth Group (UNH) had its price target raised by Bank of America Corporation from $450.00 to $475.00. They now have a "buy" rating on the stock.
Ratings data for UNH provided by MarketBeat

Einschätzung Buy
Rendite (%) 3,64 %
Kursziel 410,58
Veränderung
Endet am 30.06.27

UnitedHealth Group (UNH) was given a new $468.00 price target by Morgan Stanley. They now have an "overweight" rating on the stock.
Ratings data for UNH provided by MarketBeat

Einschätzung Buy
Rendite (%) 1,17 %
Kursziel 405,17
Veränderung
Endet am 09.07.27

UnitedHealth Group (UNH) had its price target raised by Royal Bank Of Canada from $400.00 to $463.00. They now have an "outperform" rating on the stock.
Ratings data for UNH provided by MarketBeat

Einschätzung Buy
Rendite (%) 1,33 %
Kursziel 425,59
Veränderung
Endet am 13.07.27

UnitedHealth Group (UNH) had its price target raised by Wells Fargo & Company from $397.00 to $485.00. They now have an "overweight" rating on the stock.
Ratings data for UNH provided by MarketBeat

Einschätzung Buy
Rendite (%) 1,49 %
Kursziel 416,96
Veränderung
Endet am 14.07.27

UnitedHealth Group (UNH) had its price target raised by KeyCorp from $400.00 to $475.00. They now have an "overweight" rating on the stock.
Ratings data for UNH provided by MarketBeat

Einschätzung Buy
Rendite (%) 1,82 %
Kursziel 421,34
Veränderung
Endet am 14.07.27

UnitedHealth Group (UNH) had its price target raised by Truist Financial Corporation from $440.00 to $480.00. They now have a "buy" rating on the stock.
Ratings data for UNH provided by MarketBeat

Einschätzung Buy
Rendite (%) 2,47 %
Kursziel 428,36
Veränderung
Endet am 17.07.27

UnitedHealth Group (UNH) had its price target raised by UBS Group AG from $460.00 to $490.00. They now have a "buy" rating on the stock.
Ratings data for UNH provided by MarketBeat

Einschätzung Buy
Rendite (%) 1,17 %
Kursziel 417,87
Veränderung
Endet am 17.07.27

UnitedHealth Group (UNH) had its price target raised by Royal Bank Of Canada from $463.00 to $478.00. They now have an "outperform" rating on the stock.
Ratings data for UNH provided by MarketBeat

Einschätzung Buy
Rendite (%) 1,22 %
Kursziel 437,10
Veränderung
Endet am 17.07.27

UnitedHealth Group (UNH) had its price target raised by Oppenheimer Holdings, Inc. from $420.00 to $500.00. They now have an "outperform" rating on the stock.
Ratings data for UNH provided by MarketBeat

Einschätzung Buy
Rendite (%) 0,42 %
Kursziel 462,45
Veränderung
Endet am 17.07.27

UnitedHealth Group (UNH) had its price target raised by Morgan Stanley from $468.00 to $529.00. They now have an "overweight" rating on the stock.
Ratings data for UNH provided by MarketBeat

Einschätzung Buy
Rendite (%) 3,08 %
Kursziel 385,43
Veränderung
Endet am 20.07.27

UnitedHealth Group (UNH) had its price target raised by Barclays PLC from $429.00 to $441.00. They now have an "overweight" rating on the stock.
Ratings data for UNH provided by MarketBeat

UnitedHealth Group (UNH) had its "outperform" rating reaffirmed by Sanford C. Bernstein.
Ratings data for UNH provided by MarketBeat

Einschätzung Buy
Rendite (%) 0,69 %
Kursziel 452,22
Veränderung
Endet am 21.07.27

UnitedHealth Group (UNH) had its price target raised by JPMorgan Chase & Co. from $466.00 to $516.00. They now have an "overweight" rating on the stock.
Ratings data for UNH provided by MarketBeat